![]() ![]() ![]() Reports are encouraging on the drug's results so far. Flibanserin (brand name Addyi) was approved in 2015 for premenopausal women who do not have underlying physical or psychological causes for their disorder. Food and Drug Administration to treat low sexual desire in women. When a physical or emotional problem persists, it's time to contact a health care professional.įor the first time, there's even a drug approved by the U.S. Women can experience a variety of sexual problems, such as lack of desire, difficulty becoming aroused or having an orgasm or having pain during sex. Instead, women needlessly suffer in silence when their problems could be treated. Yet, many women hesitate to talk about their sexuality with their health care professionals, and many health professionals are reluctant to begin a discussion about sexuality with their patients. A sexual problem can hurt her personal relationships and her self-esteem. A woman's sexuality is a complex interplay of physical and emotional responses that affects the way she thinks and feels about herself.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |